418 related articles for article (PubMed ID: 28834221)
1. Tolerance after liver transplantation: Where are we?
Feng S; Bucuvalas J
Liver Transpl; 2017 Dec; 23(12):1601-1614. PubMed ID: 28834221
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.
Feng S; Bucuvalas JC; Mazariegos GV; Magee JC; Sanchez-Fueyo A; Spain KM; Lesniak A; Kanaparthi S; Perito E; Venkat VL; Burrell BE; Alonso EM; Bridges ND; Doo E; Gupta NA; Himes RW; Ikle D; Jackson AM; Lobritto SJ; Jose Lozano J; Martinez M; Ng VL; Rand EB; Sherker AH; Sundaram SS; Turmelle YP; Wood-Trageser M; Demetris AJ
Hepatology; 2021 May; 73(5):1985-2004. PubMed ID: 32786149
[TBL] [Abstract][Full Text] [Related]
3. Tolerance in clinical liver transplantation.
Levitsky J; Feng S
Hum Immunol; 2018 May; 79(5):283-287. PubMed ID: 29054397
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression in pediatric liver transplant recipients: Unique aspects.
Miloh T; Barton A; Wheeler J; Pham Y; Hewitt W; Keegan T; Sanchez C; Bulut P; Goss J
Liver Transpl; 2017 Feb; 23(2):244-256. PubMed ID: 27874250
[TBL] [Abstract][Full Text] [Related]
5.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
6. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.
Feng S; Ekong UD; Lobritto SJ; Demetris AJ; Roberts JP; Rosenthal P; Alonso EM; Philogene MC; Ikle D; Poole KM; Bridges ND; Turka LA; Tchao NK
JAMA; 2012 Jan; 307(3):283-93. PubMed ID: 22253395
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the operationally tolerant liver allograft recipient.
Castellaneta A; Thomson AW; Nayyar N; de Vera M; Mazariegos GV
Curr Opin Organ Transplant; 2010 Feb; 15(1):28-34. PubMed ID: 19890211
[TBL] [Abstract][Full Text] [Related]
8. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance.
de la Garza RG; Sarobe P; Merino J; Lasarte JJ; D'Avola D; Belsue V; Delgado JA; Silva L; Iñarrairaegui M; Sangro B; Sola JJ; Pardo F; Quiroga J; Herrero JI
Liver Transpl; 2013 Sep; 19(9):937-44. PubMed ID: 23784747
[TBL] [Abstract][Full Text] [Related]
9. Minimization of immunosuppression in adult liver transplantation: new strategies and tools.
Londoño MC; López MC; Sánchez-Fueyo A
Curr Opin Organ Transplant; 2010 Dec; 15(6):685-90. PubMed ID: 20885324
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of 23 operational tolerant liver transplant recipients.
Tryphonopoulos P; Ruiz P; Weppler D; Nishida S; Levi DM; Moon J; Tekin A; Velez M; Neuman DR; Island E; Selvaggi G; Tzakis AG
Transplantation; 2010 Dec; 90(12):1556-61. PubMed ID: 21085060
[TBL] [Abstract][Full Text] [Related]
11. Pediatric liver transplantation: Personal perspectives on historical achievements and future challenges.
Otte JB
Liver Transpl; 2016 Sep; 22(9):1284-94. PubMed ID: 27096329
[TBL] [Abstract][Full Text] [Related]
12. Balancing immunosuppression in pediatric liver transplantation: Playing the long game.
Antala S; DiNorcia J; Bucuvalas J
Pediatr Transplant; 2023 Dec; 27(8):e14575. PubMed ID: 37439035
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation: Rejection and tolerance.
Taner T
Liver Transpl; 2017 Oct; 23(S1):S85-S88. PubMed ID: 28779559
[No Abstract] [Full Text] [Related]
14. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation.
Koshiba T; Li Y; Takemura M; Wu Y; Sakaguchi S; Minato N; Wood KJ; Haga H; Ueda M; Uemoto S
Transpl Immunol; 2007 Feb; 17(2):94-7. PubMed ID: 17306739
[TBL] [Abstract][Full Text] [Related]
15. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
Baron D; Giral M; Brouard S
Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
[TBL] [Abstract][Full Text] [Related]
16. Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments.
Kelly D; Verkade HJ; Rajanayagam J; McKiernan P; Mazariegos G; Hübscher S
Liver Transpl; 2016 Nov; 22(11):1593-1602. PubMed ID: 27543906
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective.
Demetris AJ; Lunz JG; Randhawa P; Wu T; Nalesnik M; Thomson AW
Transpl Int; 2009 Jan; 22(1):120-41. PubMed ID: 18980624
[TBL] [Abstract][Full Text] [Related]
18. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.
Sarwal MM
Clin Biochem; 2016 Mar; 49(4-5):404-10. PubMed ID: 26794635
[TBL] [Abstract][Full Text] [Related]
19. The need for minimization strategies: current problems of immunosuppression.
Bamoulid J; Staeck O; Halleck F; Khadzhynov D; Brakemeier S; Dürr M; Budde K
Transpl Int; 2015 Aug; 28(8):891-900. PubMed ID: 25752992
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.
Perito ER; Martinez M; Turmelle YP; Mason K; Spain KM; Bucuvalas JC; Feng S
Am J Transplant; 2019 May; 19(5):1545-1551. PubMed ID: 30614623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
